Clinical Trial

Association of Arterio-Venous Oxygen and Carbon Dioxide Gradients With Tissue Hypoperfusion and Mortality in Sepsis

Completed
View on ClinicalTrials.gov →
Summary
In patients with sepsis who are treated in the intensive care unit under invasive mechanical ventilation, the combined evaluation of ScvO₂ and PcvCO₂ may provide a comprehensive insight into tissue oxygenation and metabolic stress, allowing a more precise hemodynamic assessment in critically ill patients. The aim of this study is to evaluate the monitoring of ScvO₂, PcvCO₂, and EtCO₂ in intensive care patients in order to predict hemodynamic instability, 28-day mortality, and length of ICU stay, as well as to investigate their effects on cardiac output, tissue oxygenation, and hypoperfusion.
Trial Details
NCT Number NCT07711405
Lead Sponsor Gaziosmanpasa Research and Education Hospital
Conditions Intubated ICU Patients, Sepsis and Septic Shock
Enrollment 88 participants
Start Date 2025-03-01
Primary Completion 2025-09-20 (estimated)
Study Completion 2026-01-13 (estimated)
Updated on ClinicalTrials.gov 2026-07-17